Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease With Systemic Sclerosis”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Testing effectiveness (Phase 2)Study completedNCT00764309
What this trial is testing

Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis

Who this might be right for
Scleroderma
Bristol-Myers Squibb 47
Large-scale testing (Phase 3)Study completedNCT00319033
What this trial is testing

Open-label Study With Bosentan in Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseScleroderma
Actelion 132
Early research (Phase 1)Study completedNCT03675581
What this trial is testing

Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 17
Large-scale testing (Phase 3)Not Yet RecruitingNCT06549231
What this trial is testing

Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis

Who this might be right for
Interstitial Lung Disease With Systemic Sclerosis
University Hospital, Tours 102
Not applicableNot Yet RecruitingNCT06615128
What this trial is testing

Assessment of Serum CD25 Level in Systemic Sclerosis Patients with or Without Interstitial Lung Disease (ILD)

Who this might be right for
Assessment of Serum Level of SCD25 in RA, SSc (with or Without ILD) and IPF and Its Correlation with Disease Activity
Assiut University 66
Testing effectiveness (Phase 2)Study completedNCT01988506
What this trial is testing

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisSystemic Lupus Erythematosus+11 more
Assistance Publique - Hôpitaux de Paris 81
Large-scale testing (Phase 3)Study completedNCT02896205
What this trial is testing

Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease

Who this might be right for
Systemic SclerosisSclerodermaInterstitial Lung Disease
Post Graduate Institute of Medical Education and Research, Chandigarh 41
Not applicableUnknownNCT05445817
What this trial is testing

Pulmonary Care and Research Collaborative Patient Registry

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 150
Not applicableStudy completedNCT03430388
What this trial is testing

Yellow Fever Vaccine in Patients With Rheumatic Diseases

Who this might be right for
Systemic LupusRheumatoid ArthritisSpondyloarthritis+8 more
University of Sao Paulo General Hospital 600
Not applicableUnknownNCT03858842
What this trial is testing

Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017

Who this might be right for
Lung Diseases, InterstitialLung Disease With Systemic Sclerosis
Hospices Civils de Lyon 100
Not applicableLooking for participantsNCT05345795
What this trial is testing

Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
Central Hospital, Nancy, France 600
Large-scale testing (Phase 3)Study completedNCT00070590
What this trial is testing

Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma

Who this might be right for
Pulmonary FibrosisScleroderma, Systemic
Actelion 132
Testing effectiveness (Phase 2)Looking for participantsNCT07047690
What this trial is testing

Nemolizumab for the Treatment of Adults With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Galderma R&D 162
Large-scale testing (Phase 3)Study completedNCT00004563
What this trial is testing

Scleroderma Lung Disease

Who this might be right for
Lung DiseasesPulmonary FibrosisSystemic Scleroderma+1 more
The University of Texas Health Science Center, Houston 158
Not applicableWithdrawnNCT05177471
What this trial is testing

Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung Disease

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
Central Hospital, Nancy, France
Testing effectiveness (Phase 2)Ended earlyNCT02745145
What this trial is testing

Abituzumab in SSc-ILD

Who this might be right for
Systemic Sclerosis-associated Interstitial Lung Disease
EMD Serono Research & Development Institute, Inc. 24
Large-scale testing (Phase 3)Looking for participantsNCT06297096
What this trial is testing

Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland 86
Large-scale testing (Phase 3)Study completedNCT03313180
What this trial is testing

A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 444
Large-scale testing (Phase 3)Looking for participantsNCT06716606
What this trial is testing

Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

Who this might be right for
Connective Tissue Diseases
GlaxoSmithKline 514
Testing effectiveness (Phase 2)Looking for participantsNCT06350110
What this trial is testing

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisAutoimmune Diseases+6 more
Essen Biotech 75
Load More Results